Share This

Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
《盈喜》精優藥業料中期虧轉盈 賺最多1.05億元

2024-11-19T  
盧寵茂:「1+」機制累計批出5款新藥申請 其中2款藥物成本下降近30%

2024-11-08T  
康哲藥業磷酸蘆可替尼乳膏香港新藥上市申請獲批

2024-11-06T  
微創醫療附屬心脈醫療科技首九個月賺5.53億人民幣 增長42.5%

2024-10-30T  
衛生署:「1+」審批機制11月起擴展至所有新藥 體現「好藥港用」

2024-10-25T  
《施政報告》加快改革藥械審批制度 體現「好藥港用」

2024-10-16T  
《港股》恆指半日跌282點 車股及消費股弱 潤啤挫逾8%

2024-10-15T  
《大行》匯豐研究:中國市場焦點或從政策轉向基本面 六行業受惠

2024-10-15T  
《港股》恆指收跌289點 建材、基建、券商及醫藥股下滑 美團小鵬逆漲

2024-10-09T  
精優藥業核數師任期屆滿後退任

2024-08-12T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.